Table 3.
Characteristic or Outcome | CLSa (n = 11) | RALSa (n = 14) | P Value |
---|---|---|---|
Ageb (range) (y) | 40 (32–50) | 42.5 (36–45) | >.99 |
ORTa (range) (min)b | 174 (130–270) | 282.5 (224–342) | .0255d |
EBLa (range) (mL)b | 150 (10–200) | 100 (50–200) | .6606 |
Hysterectomyc | .6619 | ||
None | 8 (73%) | 9 (64%) | |
Simple | 3 (27%) | 3 (21%) | |
Radical | 0 (0%) | 2 (14%) | |
Hysteroscopyc | .6951 | ||
Not performed | 5 (45%) | 8 (57%) | |
Performed | 6 (55%) | 13 (43%) | |
No. of intraoperative complicationsc | NEa | ||
0 | 11 (100%) | 14 (100%) | |
1 | 0 (0%) | 0 (0%) | |
No. of postoperative complicationsc | .2878 | ||
0 | 8 (73%) | 3 (93%) | |
1 | 3 (27%) | 1 (7%) | |
2 | 0 (0%) | 0 (0%) | |
3 | 0 (0%) | 0 (0%) | |
LOSa (range) (d)b | 1 (0–2) | 1 (0–1) | .8626 |
BMI = body mass index; CLS = conventional laparoscopic surgery; EBL = estimated blood loss; LOS = length of stay in hospital after surgery; NE = not estimable (neither group has any complications); RALS = robotic-assisted laparoscopic surgery.
Wilcoxon rank sum test at 5% (2-sided) level of significance.
Chi-square test, or Fisher exact test when expected cell counts were <5, at 5% (2-sided) level of significance.
P < .05.